Sealing of a drain hole using 2-octylcyanoacrylate monomer after lymphadenectomy for gynecologic cancer

In this study, the authors investigated whether lymphocele infection can be prevented using 2-octyl cyanoacrylate monomer, a skin closure material that provides a microbial barrier. The subjects were 34 patients treated with 2-octyl cyanoacrylate monomer to close the drain hole (n=17) or with natural drain closure only (n=17). In the control group, eight cases (47.1%) had leakage of lymph fluid that required regular changes of dressing after removal of the catheter, seven (41.1%) had lymphocele, and three (17.6%) developed lymphocele with infection. In contrast, in the 2-octyl cyanoacrylate monomer group, no cases had long-term leakage of lymph fluid and none required dressing changes, although three had leakage after the first application and required a second application of 2-octyl cyanoacrylate monomer for closure. Six cases (35.3%) had lymphocele and there were no cases with infection in the 2-octyl cyanoacrylate monomer group. 2-octyl cyanoacrylate monomer may contribute to reduction of the incidence of lymphocele infection and reduce the clinical burden caused by dressing changes.

Lymphadenectomy; Lymphocele; 2-octyl cyanoacrylate monomer.

[1] Weinberger V., Cibula D., Zikan M.: “Lymphocele: prevalence and management in gynecological malignancies”. Expert Rev. Anticancer Ther., 2014, 14, 307.

[2] Querleu D., Leblanc E., Cartron G., Narducci F., Ferron G., Martel P.: “Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients”. Am. J. Obstet. Gynecol., 2006, 195, 1287.

[3] Panici P.B., Plotti F., Zullo M.A., Muzii L., Manci N., Palaia I., et al.: “Pelvic lymphadenectomy for cervical carcinoma: laparotomy extraperitoneal, transperitoneal or laparoscopic approach? A randomized study”. Gynecol. Oncol., 2006, 103, 859.

[4] Tam K.F., Lam K.W., Chan K.K., Ngan H.Y.: “Natural history of pelvic lymphocysts as observed by ultrasonography after bilateral pelvic lymphadenectomy”. Ultrasound Obstet. Gynecol., 2008, 32, 87.

[5] Kim H.Y., Kim J.W., Kim S.H., Kim Y.T., Kim J.H.: “An analysis of the risk factors and management of lymphocele after pelvic lymphadenectomy in patients with gynecologic malignancies”. Cancer Res. Treat., 2004, 36, 377.

[6] Achouri A., Huchon C., Bats A.S., Bensaid C., Nos C., Lécuru F.: “Complications of lymphadenectomy for gynecologic cancer”. Eur. J. Surg. Oncol., 2013, 39, 81.

[7] Franchi M., Trimbos J.B., Zanaboni F., v d Velden J., Reed N., Coens C., et al.: “Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) study in 234 patients”. Eur. J. Cancer, 2007, 43, 1265.

[8] Bifulco G., Giampaolino P., Morra I., Tommaselli G.A., Tarsitano F., Chiacchio G., et al.: “Synthetic cyanoacrylic glue in the prevention of post-operative lymphocele after pelvic lymphadenectomy in patients with uterine malignancies: A prospective, single-blind, preliminary study”. Gynecol. Oncol., 2014, 134, 556.

[9] Scholz H.S., Petru E., Benedicic C., Haas J., Tamussino K., Winter R.: “Fibrin application for preventing lymphocysts after retroperitoneal lymphadenectomy in patients with gynecologic malignancies”. Gynecol. Oncol., 2002, 84, 43.

[10] Rohaizak M., Khan F.J., Jasmin J.S., Mohd Latar N.H., Abdullah S.S.: “Ultracision versus electrocautery in performing modified radical mastectomy and axillary lymph node dissection for breast cancer: a prospective randomized control trial”. Med. J. Malaysia, 2013, 68, 204.

[11] Gallotta V., Fanfani F., Rossitto C., Vizzielli G., Testa A., Scambia G., et al.: “A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer”. Am. J. Obstet. Gynecol., 2010, 203, 483.e1.

[12] Carcoforo P., Soliani G., Maestroni U., Donini A., Inderbitzin D., Hui T.T., et al.: “Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial”. J. Am. Coll. Surg., 2003, 196, 365.

[13] Mahmoud S.A., Abdel-Elah K., Eldesoky A.H., El-Awady S.I.: “Octreotide can control lymphorrhea after axillary node dissection in mastectomy operations”. Breast J., 2007, 13, 108.

[14] Kim W.T., Ham W.S., Koo K.C., Choi Y.D.: “Efficacy of octreotide for management of lymphorrhea after pelvic lymph node dissection in radical prostatectomy”. Urology, 2010, 76, 398.

[15] Gennari R., Rotmensz N., Ballardini B., Scevola S., Perego E., Zanini V., et al.: “A prospective, randomized, controlled clinical trial of tissue adhesive (2-octylcyanoacrylate) versus standard wound closure in breast surgery”. Surgery, 2004, 136, 593.

[16] Ong J., Ho K.S., Chew M.H., Eu K.W.: “Prospective randomised study to evaluate the use of DERMABOND ProPen (2-octylcyanoacrylate) in the closure of abdominal wounds versus closure with skin staples in patients undergoing elective colectomy”. Int. J. Colorectal Dis., 2010, 25, 899.

[17] Singer A.J., Quinn J.V., Clark R.E., Hollander J.E., TraumaSeal Study Group: “Closure of lacerations and incisions with octylcyanoacrylate: a multicenter randomized controlled trial”. Surgery, 2002, 131, 270.

[18] Bernard L, Doyle J., Friedlander S.F., Eichenfield L.F., Gibbs N.F., Cunningham B.B.: “A prospective comparison of octyl cyanoacrylate tissue adhesive (dermabond) and suture for the closure of excisional wounds in children and adolescents”. Arch. Dermatol., 2001, 137, 1177.

[19] Bhende S., Rothenburger S., Spangler D.J., Dito M.: “In vitro assessment of microbial barrier properties of Dermabond topical skin adhesive”. Surg. Infect. (Larchmt.), 2002, 3, 251.

[20] Souza E.C., Fitaroni R.B., Januzelli D.M., Macruz H.M., Camacho J.C., Souza M.R.: “Use of 2-octyl cyanoacrylate for skin closure of sternal incisions in cardiac surgery: observations of microbial barrier effects”. Curr. Med. Res. Opin., 2008, 24, 151.

[21] Hivnor C.M., Hudkins M.L.: “Allergic contact dermatitis after postsurgical repair with 2-octylcyanoacrylate”. Arch. Dermatol., 2008, 144, 814.